Cargando…

Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence

Reports suggest an increased risk of tuberculosis (TB) in people with chronic airway diseases (CADs) such as chronic obstructive pulmonary disease (COPD), but evidence has not been systematically reviewed. We performed a systematic review by searching MEDLINE and Embase for studies published from 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamada, Yohhei, Fong, Christopher J, Copas, Andrew, Hurst, John R, Rangaka, Molebogeng X
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070518/
https://www.ncbi.nlm.nih.gov/pubmed/34383072
http://dx.doi.org/10.1093/trstmh/trab122
_version_ 1784700657853267968
author Hamada, Yohhei
Fong, Christopher J
Copas, Andrew
Hurst, John R
Rangaka, Molebogeng X
author_facet Hamada, Yohhei
Fong, Christopher J
Copas, Andrew
Hurst, John R
Rangaka, Molebogeng X
author_sort Hamada, Yohhei
collection PubMed
description Reports suggest an increased risk of tuberculosis (TB) in people with chronic airway diseases (CADs) such as chronic obstructive pulmonary disease (COPD), but evidence has not been systematically reviewed. We performed a systematic review by searching MEDLINE and Embase for studies published from 1 January 1993 to 15 January 2021 reporting the association between the incident risk of TB in people with CADs (asthma, COPD and bronchiectasis). Two reviewers independently assessed the quality of individual studies. We included nine studies, with two from low-income high TB burden countries. Three cohort studies reported a statistically significant independent association between COPD and the risk of TB in high-income countries (n=711 389). Hazard ratios for incident TB ranged from 1.44 to 3.14 adjusted for multiple confounders including age, sex and comorbidity. There was large between-study heterogeneity (I(2)=97.0%) across studies. The direction of effect on the TB risk from asthma was inconsistent. Chronic bronchitis or bronchiectasis studies were limited. The small number of available studies demonstrated an increased risk of TB in people with COPD; however, the magnitude of the increase varies by setting and population. Data in high TB burden countries and for other CADs are limited.
format Online
Article
Text
id pubmed-9070518
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-90705182022-05-06 Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence Hamada, Yohhei Fong, Christopher J Copas, Andrew Hurst, John R Rangaka, Molebogeng X Trans R Soc Trop Med Hyg Review Article Reports suggest an increased risk of tuberculosis (TB) in people with chronic airway diseases (CADs) such as chronic obstructive pulmonary disease (COPD), but evidence has not been systematically reviewed. We performed a systematic review by searching MEDLINE and Embase for studies published from 1 January 1993 to 15 January 2021 reporting the association between the incident risk of TB in people with CADs (asthma, COPD and bronchiectasis). Two reviewers independently assessed the quality of individual studies. We included nine studies, with two from low-income high TB burden countries. Three cohort studies reported a statistically significant independent association between COPD and the risk of TB in high-income countries (n=711 389). Hazard ratios for incident TB ranged from 1.44 to 3.14 adjusted for multiple confounders including age, sex and comorbidity. There was large between-study heterogeneity (I(2)=97.0%) across studies. The direction of effect on the TB risk from asthma was inconsistent. Chronic bronchitis or bronchiectasis studies were limited. The small number of available studies demonstrated an increased risk of TB in people with COPD; however, the magnitude of the increase varies by setting and population. Data in high TB burden countries and for other CADs are limited. Oxford University Press 2021-08-12 /pmc/articles/PMC9070518/ /pubmed/34383072 http://dx.doi.org/10.1093/trstmh/trab122 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Hamada, Yohhei
Fong, Christopher J
Copas, Andrew
Hurst, John R
Rangaka, Molebogeng X
Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence
title Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence
title_full Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence
title_fullStr Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence
title_full_unstemmed Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence
title_short Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence
title_sort risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070518/
https://www.ncbi.nlm.nih.gov/pubmed/34383072
http://dx.doi.org/10.1093/trstmh/trab122
work_keys_str_mv AT hamadayohhei riskfordevelopmentofactivetuberculosisinpatientswithchronicairwaydiseaseasystematicreviewofevidence
AT fongchristopherj riskfordevelopmentofactivetuberculosisinpatientswithchronicairwaydiseaseasystematicreviewofevidence
AT copasandrew riskfordevelopmentofactivetuberculosisinpatientswithchronicairwaydiseaseasystematicreviewofevidence
AT hurstjohnr riskfordevelopmentofactivetuberculosisinpatientswithchronicairwaydiseaseasystematicreviewofevidence
AT rangakamolebogengx riskfordevelopmentofactivetuberculosisinpatientswithchronicairwaydiseaseasystematicreviewofevidence